121 related articles for article (PubMed ID: 16556138)
1. Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects.
Hashiba H; Aizawa S; Tamura K; Kogo H
Ther Apher Dial; 2006 Feb; 10(1):59-64. PubMed ID: 16556138
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients.
Hashiba H; Aizawa S; Tamura K; Shigematsu T; Kogo H
Ther Apher Dial; 2004 Jun; 8(3):241-7. PubMed ID: 15154878
[TBL] [Abstract][Full Text] [Related]
3. Prevention of aortic calcification by etidronate in the renal failure rat model.
Tamura K; Suzuki Y; Matsushita M; Fujii H; Miyaura C; Aizawa S; Kogo H
Eur J Pharmacol; 2007 Mar; 558(1-3):159-66. PubMed ID: 17270170
[TBL] [Abstract][Full Text] [Related]
4. [Suppressive effects of bisphosphonates on the vascular calcification in ESRD patients].
Tamura K; Hashiba H; Kogo H; Aizawa S; Shigematsu T
Clin Calcium; 2002 Aug; 12(8):1129-35. PubMed ID: 15775409
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium.
Shiraishi N; Kitamura K; Miyoshi T; Adachi M; Kohda Y; Nonoguchi H; Misumi S; Maekawa Y; Murayama T; Tomita M; Tomita K
Am J Kidney Dis; 2006 Jul; 48(1):151-4. PubMed ID: 16797398
[TBL] [Abstract][Full Text] [Related]
6. Etidronate for the treatment of progressive tumoral calcinosis in hemodialysis patients.
Mori H; Okada Y; Tanaka Y
Intern Med; 2007; 46(17):1485-6. PubMed ID: 17827857
[No Abstract] [Full Text] [Related]
7. Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease.
Arase Y; Suzuki F; Suzuki Y; Akuta N; Kobayashi M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Ikeda K; Kumada H
J Med Virol; 2008 Jul; 80(7):1302-7. PubMed ID: 18461628
[TBL] [Abstract][Full Text] [Related]
8. Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis.
Nitta K; Akiba T; Suzuki K; Uchida K; Watanabe R; Majima K; Aoki T; Nihei H
Am J Kidney Dis; 2004 Oct; 44(4):680-8. PubMed ID: 15384019
[TBL] [Abstract][Full Text] [Related]
9. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
Sato S; Takada T; Katsuki Y; Kimura N; Kaneko Y; Suwa A; Hirakata M; Kuwana M
J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368
[TBL] [Abstract][Full Text] [Related]
10. Effect of etidronic acid on arterial calcification in dialysis patients.
Ariyoshi T; Eishi K; Sakamoto I; Matsukuma S; Odate T
Clin Drug Investig; 2006; 26(4):215-22. PubMed ID: 17163254
[TBL] [Abstract][Full Text] [Related]
11. [Regression of severe periarticular calcifications during treatment with bisphosphonate in a dialysis patient].
Obad D; Larsen NA; Pedersen EB
Ugeskr Laeger; 2010 Mar; 172(9):719-21. PubMed ID: 20199755
[TBL] [Abstract][Full Text] [Related]
12. [Evidence and utility of etidronate for the treatment of osteoporosis].
Takada J; Iba K; Yamashita T; Yoshizaki T
Clin Calcium; 2008 Oct; 18(10):1427-33. PubMed ID: 18830039
[TBL] [Abstract][Full Text] [Related]
13. Short-term etidronate treatment prevents glucocorticoid-induced bone debility of the mandible in growing rats.
Fujita Y; Konoo T; Maki K
Orthod Craniofac Res; 2008 Nov; 11(4):187-95. PubMed ID: 18950314
[TBL] [Abstract][Full Text] [Related]
14. [Positioning of bisphosphonates for vascular calcification].
Okada Y; Mori H; Tanaka Y; Hashimoto O
Clin Calcium; 2010 Nov; 20(11):1711-7. PubMed ID: 21037392
[TBL] [Abstract][Full Text] [Related]
15. Phytate inhibits bovine pericardium calcification in vitro.
Grases F; Sanchis P; Costa-Bauzá A; Bonnin O; Isern B; Perelló J; Prieto RM
Cardiovasc Pathol; 2008; 17(3):139-45. PubMed ID: 18402805
[TBL] [Abstract][Full Text] [Related]
16. The use of eidronate disodium in the prevention of heterotopic ossification in burn patients.
Shafer DM; Bay C; Caruso DM; Foster KN
Burns; 2008 May; 34(3):355-60. PubMed ID: 17869001
[TBL] [Abstract][Full Text] [Related]
17. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.
Morishita M; Nagashima M; Wauke K; Takahashi H; Takenouchi K
J Rheumatol; 2008 Mar; 35(3):407-13. PubMed ID: 18260178
[TBL] [Abstract][Full Text] [Related]
18. Effects of etidronate on the Enpp1⁻/⁻ mouse model of generalized arterial calcification of infancy.
Huesa C; Staines KA; Millán JL; MacRae VE
Int J Mol Med; 2015 Jul; 36(1):159-65. PubMed ID: 25975272
[TBL] [Abstract][Full Text] [Related]
19. Pilot study to evaluate the safety and effectiveness of etidronate treatment for arterial calcification due to deficiency of CD73 (ACDC).
Ferrante EA; Cudrici CD; Rashidi M; Fu YP; Huffstutler R; Carney K; Chen MY; St Hilaire C; Smith K; Bagheri H; Katz JD; Ferreira CR; Gahl WA; Boehm M; Brofferio A
Vasc Med; 2024 Jun; 29(3):245-255. PubMed ID: 38568107
[TBL] [Abstract][Full Text] [Related]
20. Vascular calcification and disordered mineral metabolism in dialysis patients.
Kalpakian MA; Mehrotra R
Semin Dial; 2007; 20(2):139-43. PubMed ID: 17374088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
